Skip to main content

MoneyWorks4Me

Hester Biosciences informs about newspaper publication

07 Nov 2022 Evaluate

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has submitted a copy of the published extract of consolidated unaudited financial results for the quarter and half year ended 30 September 2022 along with information on standalone financial results. The same was published on Saturday, 5 November 2022 in the Ahmedabad edition of Financial Express (English) and Financial Express (Gujarati).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..